Pfizer Submits Favorable Initial Data To The FDA On Kids' COVID-19 Vaccine Trial
Pfizer and BioNTech say they plan to submit a formal request for emergency use authorization of their vaccine in young children "in the coming weeks."
Full Article
Pfizer Submits Favorable Initial Data To The FDA On Kids' COVID-19 Vaccine Trial
NPR
0 shares
1 views
You might like
Related news coverage
Pfizer submits data to FDA for Covid-19 vaccine in younger children
(MENAFN - Gulf Times) Pfizer Inc and BioNTech SE submitted initial trial data for their Covid-19 vaccine in children aged 5 to 11..
MENAFN.com
Pfizer submits promising data to FDA from vaccine trial with kids ages 5-11
Pfizer and BioNTech have submitted data to the U.S. Food and Drug Administration on Tuesday from a trial on the effects of the..
PIX 11